Qube Research & Technologies Ltd - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,922,763
+49.4%
71,558
+98.2%
0.01%0.0%
Q2 2023$1,287,148
+4.2%
36,095
-25.8%
0.01%0.0%
Q1 2023$1,234,897
+133.0%
48,618
+321.8%
0.01%
+25.0%
Q1 2022$530,000
-72.8%
11,526
-51.0%
0.00%
-81.8%
Q2 2021$1,948,000
+472.9%
23,520
+339.1%
0.02%
+100.0%
Q4 2019$340,0005,3570.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders